Terms: = Head and neck cancer AND IDH2, P48735, 3418, ENSG00000182054, IDHM, mNADP-IDH, IDH, IDP, ICD-M AND Treatment
21 results:
1. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
2. Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells.
Nelde A; Schuster H; Heitmann JS; Bauer J; Maringer Y; Zwick M; Volkmer JP; Chen JY; Stanger AMP; Lehmann A; Appiah B; Märklin M; Rücker-Braun E; Salih HR; Roerden M; Schroeder SM; Häring MF; Schlosser A; Schetelig J; Schmitz M; Boerries M; Köhler N; Lengerke C; Majeti R; Weissman IL; Rammensee HG; Walz JS
Blood Cancer Discov; 2023 Nov; 4(6):468-489. PubMed ID: 37847741
[TBL] [Abstract] [Full Text] [Related]
3. Machine learning to improve interpretability of clinical, radiological and panel-based genomic data of glioma grade 4 patients undergoing surgical resection.
Dal Bo M; Polano M; Ius T; Di Cintio F; Mondello A; Manini I; Pegolo E; Cesselli D; Di Loreto C; Skrap M; Toffoli G
J Transl Med; 2023 Jul; 21(1):450. PubMed ID: 37420248
[TBL] [Abstract] [Full Text] [Related]
4. idh2 -Mutated Sinonasal Tumors: A Review.
Alzumaili B; Sadow PM
Adv Anat Pathol; 2023 Mar; 30(2):104-111. PubMed ID: 36537260
[TBL] [Abstract] [Full Text] [Related]
5. Olfactory Neuroblastoma: Morphological Reappraisal and Molecular Insights with Quantum Leap in Clinical Perspectives.
Bell D; Brandea AI; Hanna EY
Curr Oncol Rep; 2023 Jan; 25(1):11-18. PubMed ID: 36449116
[TBL] [Abstract] [Full Text] [Related]
6. Standard or extended STUPP? Optimal duration of temozolomide for patients with high-grade gliomas: a retrospective analysis.
Wang J; Huang Y; Zhao F; Chen J; He L; Liu Z; Pei Y; Wei Z; Li R; Ai P; Peng X
J Neurooncol; 2022 Nov; 160(2):433-443. PubMed ID: 36357822
[TBL] [Abstract] [Full Text] [Related]
7. Radiomic study on preoperative multi-modal magnetic resonance images identifies idh-mutant TERT promoter-mutant gliomas.
Wang H; Zhang S; Xing X; Yue Q; Feng W; Chen S; Zhang J; Xie D; Chen N; Liu Y
Cancer Med; 2023 Feb; 12(3):2524-2537. PubMed ID: 36176070
[TBL] [Abstract] [Full Text] [Related]
8. Genetic variation within the human papillomavirus type 16 genome is associated with oropharyngeal cancer prognosis.
Lang Kuhs KA; Faden DL; Chen L; Smith DK; Pinheiro M; Wood CB; Davis S; Yeager M; Boland JF; Cullen M; Steinberg M; Bass S; Wang X; Liu P; Mehrad M; Tucker T; Lewis JS; Ferris RL; Mirabello L
Ann Oncol; 2022 Jun; 33(6):638-648. PubMed ID: 35306154
[TBL] [Abstract] [Full Text] [Related]
9. Luminescent Pyrrole-Based Phosphaphenalene Gold Complexes: Versatile Anticancer Tools with Wide Applicability.
Fermi V; Regulska E; Wolfram A; Wessling P; Rominger F; Herold-Mende C; Romero-Nieto C
Chemistry; 2022 Jun; 28(34):e202104535. PubMed ID: 35293640
[TBL] [Abstract] [Full Text] [Related]
10. Emerging concepts in sinonasal tumor research.
Lopez DC; Wadley AE; London NR
Curr Opin Otolaryngol Head Neck Surg; 2022 Feb; 30(1):33-39. PubMed ID: 34958321
[TBL] [Abstract] [Full Text] [Related]
11. Genetic analysis of sinonasal undifferentiated carcinoma discovers recurrent SWI/SNF alterations and a novel PGAP3-SRPK1 fusion gene.
Heft Neal ME; Birkeland AC; Bhangale AD; Zhai J; Kulkarni A; Foltin SK; Jewell BM; Ludwig ML; Pinatti L; Jiang H; McHugh JB; Marentette L; McKean EL; Brenner JC
BMC Cancer; 2021 May; 21(1):636. PubMed ID: 34051734
[TBL] [Abstract] [Full Text] [Related]
12. Long non-coding RNA TP73-AS1 is a potential immune related prognostic biomarker for glioma.
Zhang B; Li Q; Wu B; Zhang S; Li L; Jin K; Li S; Li K; Wang Z; Lu Y; Xia L; Sun C
Aging (Albany NY); 2021 Feb; 13(4):5638-5649. PubMed ID: 33589576
[TBL] [Abstract] [Full Text] [Related]
13. Radiotherapy-induced glioblastoma: distinct differences in overall survival, tumor location, pMGMT methylation and primary tumor epidemiology in Hong Kong chinese patients.
Woo PYM; Lee JWY; Lam SW; Pu JKS; Chan DTM; Mak CHK; Ho JMK; Wong ST; Po YC; Lee MWY; Chan KY; Poon WS
Br J Neurosurg; 2024 Apr; 38(2):385-392. PubMed ID: 33576706
[TBL] [Abstract] [Full Text] [Related]
14. PD-1 (PDCD1) Promoter Methylation Is a Prognostic Factor in Patients With Diffuse Lower-Grade Gliomas Harboring Isocitrate Dehydrogenase (idh) Mutations.
Röver LK; Gevensleben H; Dietrich J; Bootz F; Landsberg J; Goltz D; Dietrich D
EBioMedicine; 2018 Feb; 28():97-104. PubMed ID: 29396294
[TBL] [Abstract] [Full Text] [Related]
15. An Interesting Case of Oral Inverted Ductal Papilloma.
Berridge N; Kumar M
Dent Update; 2016 Dec; 43(10):950-2. PubMed ID: 29155535
[TBL] [Abstract] [Full Text] [Related]
16. Frequent idh2 R172 mutations in undifferentiated and poorly-differentiated sinonasal carcinomas.
Dogan S; Chute DJ; Xu B; Ptashkin RN; Chandramohan R; Casanova-Murphy J; Nafa K; Bishop JA; Chiosea SI; Stelow EB; Ganly I; Pfister DG; Katabi N; Ghossein RA; Berger MF
J Pathol; 2017 Aug; 242(4):400-408. PubMed ID: 28493366
[TBL] [Abstract] [Full Text] [Related]
17. Factors Predicting Effectiveness of Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma.
Ohkura Y; Ueno M; Iizuka T; Haruta S; Tanaka T; Udagawa H
Medicine (Baltimore); 2016 Apr; 95(15):e3365. PubMed ID: 27082598
[TBL] [Abstract] [Full Text] [Related]
18. Progression of gingival squamous cell carcinoma from early to late stage after invasive dental procedure.
Hinchy NV; Jayaprakash V; Rigual N; Reid M; Frustino JL; Rossitto R; Groman A; Sullivan MA
Gen Dent; 2016; 64(2):38-43. PubMed ID: 26943087
[TBL] [Abstract] [Full Text] [Related]
19. Extensive Therapies for Extraneural Metastases from Glioblastoma, as Confirmed with the OncoScan Assay.
Xu M; Wang Y; Xu J; Yao Y; Yu WX; Zhong P
World Neurosurg; 2016 Jun; 90():698.e7-698.e11. PubMed ID: 26852708
[TBL] [Abstract] [Full Text] [Related]
20. Isocitrate dehydrogenase mutation hot spots in acute lymphoblastic leukemia and oral cancer.
Tang JY; Chang CC; Lin PC; Chang JG
Kaohsiung J Med Sci; 2012 Mar; 28(3):138-44. PubMed ID: 22385606
[TBL] [Abstract] [Full Text] [Related]
[Next]
